Publication:
Effectiveness and safety of topical calcipotriol in the treatment of flat seborrheic keratosis on the face

dc.contributor.authorPopadic, Svetlana (24830928800)
dc.contributor.authorTomanovic, Marija (58092757700)
dc.contributor.authorMinic, Snezana (35409907200)
dc.date.accessioned2025-06-12T12:14:22Z
dc.date.available2025-06-12T12:14:22Z
dc.date.issued2023
dc.description.abstractSeborrheic keratosis is the most common slow-growing, benign epithelial tumour, usually appearing on sun-exposed areas. Treatment modalities for seborrheic keratosis may be uncomfortable and/or time-consuming. We present a case series of 12 patients with solitary seborrheic keratosis localized on the face treated with 0.005% calcipotriol ointment. The treatment lasted 3–8 months and resulted in complete regression of the lesions. Remission (follow-up period) lasted from 6 to 10 years. We conclude that topical calcipotriol may be a useful treatment option for seborrheic keratosis. © 2023 The Australasian College of Dermatologists.
dc.identifier.urihttps://doi.org/10.1111/ajd.13997
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85147530005&doi=10.1111%2fajd.13997&partnerID=40&md5=937cd8d1cff9e42f04837a84b16f51a0
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/2699
dc.subjectcalcipotriol
dc.subjectcomplete regression
dc.subjectseborrheic keratosis
dc.subjecttopical treatment
dc.subjectvitamin D3 analogue
dc.titleEffectiveness and safety of topical calcipotriol in the treatment of flat seborrheic keratosis on the face
dspace.entity.typePublication

Files